RASSF8 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.003600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.383600E-01
Normal-vs-Stage2
7.365400E-01
Normal-vs-Stage3
3.473000E-01
Normal-vs-Stage4
6.173400E-01
Stage1-vs-Stage2
9.238800E-01
Stage1-vs-Stage3
3.326600E-01
Stage1-vs-Stage4
2.446000E-01
Stage2-vs-Stage3
3.334200E-01
Stage2-vs-Stage4
2.207000E-01
Stage3-vs-Stage4
5.273700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.249800E-01
Normal-vs-AfricanAmerican
6.794800E-01
Normal-vs-Asian
4.789800E-01
Caucasian-vs-AfricanAmerican
3.414800E-01
Caucasian-vs-Asian
4.113400E-01
AfricanAmerican-vs-Asian
1.519150E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.085800E-01
Normal-vs-Female
7.099400E-01
Male-vs-Female
8.104800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.498200E-01
Normal-vs-Age(41-60Yrs)
9.559600E-01
Normal-vs-Age(61-80Yrs)
5.915800E-01
Normal-vs-Age(81-100Yrs)
2.541200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.851200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.988400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.212400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.970400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.075500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.152400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.527600E-01
Normal-vs-Daily Drinker
4.530800E-01
Normal-vs-Weekly Drinker
8.462600E-01
Normal-vs-Occasional Drinker
6.718200E-01
Normal-vs-Social Drinker
8.012200E-01
Non Drinker-vs-Daily Drinker
3.824800E-01
Non Drinker-vs-Weekly Drinker
2.381000E-01
Non Drinker-vs-Occasional Drinker
3.317600E-01
Non Drinker-vs-Social Drinker
7.428400E-02
Daily Drinker-vs-Weekly Drinker
1.002150E-01
Daily Drinker-vs-Occasional Drinker
1.461180E-01
Daily Drinker-vs-Social Drinker
3.348200E-02
Weekly Drinker-vs-Occasional Drinker
7.063000E-01
Weekly Drinker-vs-Social Drinker
4.454000E-01
Occasional Drinker-vs-Social Drinker
2.442000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.803800E-01
Normal-vs-Grade 2
9.483800E-02
Normal-vs-Grade 3
1.222170E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.087200E-01
Grade 1-vs-Grade 3
3.396200E-01
Grade 1-vs-Grade 4
2.803800E-01
Grade 2-vs-Grade 3
8.631800E-01
Grade 2-vs-Grade 4
9.483800E-02
Grade 3-vs-Grade 4
1.222170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.310200E-01
Normal-vs-NonDiabetic
4.930400E-01
Diabetic-vs-NonDiabetic
4.268400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.854800E-01
Normal-vs-NoPancreatitis
5.815800E-01
Pancreatitis-vs-NoPancreatitis
8.644400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.002400E-01
Normal-vs-N1
7.648200E-01
N0-vs-N1
3.620400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.063800E-01
Normal-vs-TP53-NonMutant
8.036600E-01
TP53-Mutant-vs-TP53-NonMutant
4.492200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
